Substantia nigra pars reticulata is crucially involved in barbiturate and ethanol withdrawal in mice

Behavioural Brain Research

Volumn 218, Issue 1, 2011, Pages 152-157

  Chen, Gang ^a,b   Kozell, Laura B ^a,b   Buck, Kari J ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Convulsion; Ibotenic acid; Lesion; Sedative hypnotic; Seizure

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALCOHOL; PENTETRAZOLE; PENTOBARBITAL;

ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVULSION; DRUG DEPENDENCE; GABAERGIC TRANSMISSION; MALE; MOUSE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; SUBSTANTIA NIGRA PARS RETICULATA; WITHDRAWAL SEIZURE;

ANIMALS; BARBITURATES; ETHANOL; EXCITATORY AMINO ACID AGONISTS; IBOTENIC ACID; MALE; MICE; PENTOBARBITAL; SEIZURES; STATISTICS, NONPARAMETRIC; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANTIA NIGRA;

EID: 78650164438     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.10.025     Document Type: Article

References (61)

1. ONDCP. The economic costs of drug abuse in the United States. Washington, DC: Office of National Drug Control Policy, Executive Office of the President (Publication No. 207303); 2004.
2. Little H.J., Stephens D.N., Ripley T.L., Borlikova G., Duka T., Schubert M., et al. Alcohol withdrawal and conditioning. Alcohol Clin Exp Res 2005, 29:453-464.
3. Belknap J.K., Laursen S.E., Crabbe J.C. Ethanol and nitrous oxide produce withdrawal-induced convulsions by similar mechanisms in mice. Life Sci 1987, 41:2033-2040.
4. Belknap J.K., Danielson P.W., Lame M., Crabbe J.C. Ethanol and barbiturate withdrawal convulsions are extensively codetermined in mice. Alcohol 1988, 5:167-171.
5. Belknap J.K., Crabbe J.C., Laursen S.E. Ethanol and diazepam withdrawal convulsions are extensively codetermined in WSP and WSR mice. Life Sci 1989, 44:2075-2080.
6. Crabbe J.C., Merrill C., Belknap J.K. Acute dependence on depressant drugs is determined by common genes in mice. J Pharmacol Exp Ther 1991, 257:663-667.
7. Buck K.J., Metten P., Belknap J., Crabbe J. Quantitative trait loci affecting risk for pentobarbital withdrawal map near alcohol withdrawal loci on mouse chromosomes 1, 4, and 11. Mammal Genome 1999, 10:431-437.
8. Metten P., Crabbe J.C. Genetic determinants of severity of acute withdrawal from diazepam in mice: commonality with ethanol and pentobarbital. Pharmacol Biochem Behav 1999, 63:473-479.
9. Kliethermes C.L., Metten P., Belknap J.K., Buck K.J., Crabbe J.C. Selection for pentobarbital withdrawal severity: correlated differences in withdrawal from other sedative drugs. Brain Res 2004, 1009:17-25.
10. Shirley R.L., Walter N.A., Reilly M.T., Fehr C., Buck K.J. Mpdz is a quantitative trait gene for drug withdrawal seizures. Nat Neurosci 2004, 7:699-700.
11. Hood H.M., Metten P., Crabbe J.C., Buck K.J. Fine mapping of a sedative-hypnotic drug withdrawal locus on mouse chromosome 11. Genes Brain Behav 2006, 5:1-10.
12. Metten P., Buck K.J., Merrill C.M., Roberts A.J., Yu C.H., Crabbe J.C. Use of a novel mouse genotype to model acute benzodiazepine withdrawal. Behav Genet 2007, 37:160-170.
13. Goldstein D.B. Alcohol withdrawal reactions in mice: effects of drugs that modify neurotransmission. J Pharmacol Exp Ther 1973, 186:1-9.
14. Lutz U.C., Batra A., Kolb W., Machicao F., Maurer S., Kohnke M.D. Methylenetetrahydrofolate reductase C677T-polymorphism and its association with alcohol withdrawal seizure. Alcohol Clin Exp Res 2006, 30:1966-1971.
15. Belknap J.K. Barbiturate physical dependence in mice: effects of neuroleptics and diazepam on the withdrawal syndrome. Clin Toxicol 1978, 12:427-434.
16. Goldstein D.B., Pal N. Alcohol dependence produced in mice by inhalation of ethanol: grading the withdrawal reaction. Science 1971, 172:288-290.
17. Chan A.W., Leong F.W., Schanley D.L., Langan M.C., Penetrante M.L. A liquid diet model of chlordiazepoxide dependence in mice. Pharmacol Biochem Behav 1989, 34:839-845.
18. Kosobud A., Crabbe J.C. Ethanol withdrawal in mice bred to be genetically prone or resistant to ethanol withdrawal seizures. J Pharmacol Exp Ther 1986, 238:170-177.
19. Fehr C., Shirley R.L., Belknap J.K., Crabbe J.C., Buck KJ Congenic mapping of alcohol and pentobarbital withdrawal liability loci to a <1 centimorgan interval of murine chromosome 4: identification of Mpdz as a candidate gene. J Neurosci 2002, 22::3730-3738.
20. Morgan J.I., Cohen D.R., Hempstead J.L., Curran T. Mapping patterns of c-fos expression in the central nervous system after seizure. Science 1987, 237:192-197.
21. Herdegen T., Leah J.D. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res Brain Res Rev 1998, 28:370-490.
22. Chen G., Kozell L.B., Hitzemann R., Buck K.J. Involvement of the limbic basal ganglia in ethanol withdrawal convulsivity in mice is influenced by a chromosome 4 locus. J Neurosci 2008, 28:9840-9849.
23. Koo J.W., Han J.S., Kim J.J. Selective neurotoxic lesions of basolateral and central nuclei of the amygdala produce differential effects on fear conditioning. J Neurosci 2004, 24:7654-7662.
24. Guldin W.O., Markowitsch H.J. Epidural kainate, but not ibotenate, produces lesions in local and distant regions of the brain. A comparison of the intracerebral actions of kainic acid and ibotenic acid. J Neurosci Methods 1982, 5:83-93.
25. Markowska A., Bakke H.K., Walther B., Ursin H. Comparison of electrolytic and ibotenic acid lesions in the lateral hypothalamus. Brain Res 1985, 328:313-323.
26. Frey S., Morris R., Petrides M. A neuroanatomical method to assess the integrity of fibers of passage following ibotenate-induced damage to the central nervous system. Neurosci Res 1997, 28:285-288.
27. Herrmann G., Stunitz H., Nitsch C. Composition of ibotenic acid-induced calcifications in rat substantia nigra. Brain Res 1998, 786:205-214.
28. Nitsch C., Scotti A.L. Ibotenic acid-induced calcium deposits in rat substantia nigra. Ultrastructure of their time-dependent formation. Acta Neuropathol 1992, 85:55-70.
29. Coffey P.J., Perry V.H., Allen Y., Sinden J., Rawlins J.N. Ibotenic acid induced demyelination in the central nervous system: a consequence of a local inflammatory response. Neurosci Lett 1988, 84:178-184.
30. Paxinos G., Franklin K. The mouse brain in stereotaxic coordinates 2001, Academic Press, Orlando FL. 2nd ed.
31. Ho I.K., Harris R.A. Mechanism of action of barbiturates. Annu Rev Pharmacol Toxicol 1981, 21:83-111.
32. Goldstein A., Judson B.A. Alcohol dependence and opiate dependence: lack of relationship in mice. Science 1971, 172:290-292.
33. Flint B.A., Ho I.K. Assessment of tolerance to and physical dependence on pentobarbital, induced by multiple pellet implantation. Eur J Pharmacol 1980, 65:355-363.
34. Kater R.M., Roggin G., Tobon F., Zieve P., Iber F.L. Increased rate of clearance of drugs from the circulation of alcoholics. Am J Med Sci 1969, 258:35-39.
35. McQuarrie D., Fengl E. Effects of single doses and chronic administration of ethanol on experimental seizures in mice. J Pharmacol Exp Ther 1958, 124:264-271.
36. Metten P., Belknap J.K., Crabbe J.C. Drug withdrawal convulsions and susceptibility to convulsants after short-term selective breeding for acute ethanol withdrawal. Behav Brain Res 1998, 95:113-122.
37. Crabbe J.C., Merrill C.D., Belknap J.K. Effects of convulsants on handling-induced convulsions in mice selected for ethanol withdrawal severity. Brain Res 1991, 550:1-6.
38. Corda M.G., Orlandi M., Lecca D., Carboni G., Frau V., Giorgi O. Pentylenetetrazol-induced kindling in rats: effect of GABA function inhibitors. Pharmacol Biochem Behav 1991, 40:329-333.
39. Kulkarni S.K., George B. Pentylenetetrazol-induced kindling in animals: protective effect of BR-16A. Indian J Exp Biol 1995, 33:424-427.
40. Kozell L.B., Hitzemann R., Buck K.J. Acute alcohol withdrawal is associated with c-Fos expression in the basal ganglia and associated circuitry: C57BL/6J and DBA/2J inbred mouse strain analyses. Alcohol Clin Exp Res 2005, 29:1939-1948.
41. Chen G., Reilly M.T., Kozell L.B., Hitzemann R., Buck K.J. Differential activation of limbic circuitry associated with chronic ethanol withdrawal in DBA/2J and C57BL/6J mice. Alcohol (Fayetteville, NY) 2009, 43:411-420.
42. Yang L., Long C., Faingold C.L. Neurons in the deep layers of superior colliculus are a requisite component of the neuronal network for seizures during ethanol withdrawal. Brain Res 2001, 920:134-141.
43. Bolam J.P., Hanley J.J., Booth P.A., Bevan M.D. Synaptic organisation of the basal ganglia. J Anat 2000, 196(Pt 4):527-542.
44. Chen G., Buck K.J. Rostroventral caudate putamen involvement in ethanol-withdrawal is influenced by a chromosome 4 locus. Genes Brain Behav 2010, 9:768-776.
45. Zhu J.J., Lo F.S. Physiological properties of the output neurons in the deep layers of the superior colliculus of the rabbit. Brain Res Bull 1995, 38:495-505.
46. Browning R.A. Neuroanatomical localization of structures responsible for seizures in the GEPR: lesion studies. Life Sci 1986, 39:857-867.
47. A-active anesthetics. Eur J Neurosci 2007, 25:1417-1436.
48. Devor M., Zalkind V. Reversible analgesia, atonia, and loss of consciousness on bilateral intracerebral microinjection of pentobarbital. Pain 2001, 94:101-112.
49. A receptors in the acute and chronic effects of ethanol: a decade of progress. Psychopharmacology (Berl) 2009, 205:529-564.
50. B autoreceptor activation on ethanol potentiation of local and lateral paracapsular GABAergic synapses in the rat basolateral amygdala. Neuropharmacology 2009, 56:886-895.
51. A receptors in neocortex. Neuropharmacology 2007, 52:1160-1168.
52. Faingold C.L., N'Gouemo P., Riaz A. Ethanol and neurotransmitter interactions-from molecular to integrative effects. ProgNeurobiol 1998, 55:509-535.
53. Littleton J. Neurochemical mechanisms underlying alcohol withdrawal. Alcohol Health Res World 1998, 22:13-24.
54. Rogawski M.A. Update on the neurobiology of alcohol withdrawal seizures. Epilepsy Curr 2005, 5:225-230.
55. B receptors influence handling-induced convulsion severity in chromosome 4 congenic and DBA/2J background strain mice. Brain Res 2008, 1198:124-131.
56. 2C receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro. J Neurosci 1996, 16:7566-7573.
57. Balasubramanian S., Fam S.R., Hall R.A. GABAB receptor association with the PDZ scaffold Mupp1 alters receptor stability and function. J Biol Chem 2007, 282:4162-4171.
58. Becamel C., Figge A., Poliak S., Dumuis A., Peles E., Bockaert J., et al. Interaction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10 of the multi-PDZ domain protein MUPP1. J Biol Chem 2001, 276:12974-12982.
59. Lee H.J., Zheng J.J. PDZ domains and their binding partners: structure, specificity, and modification. Cell Commun Signal 2010, 8:8.
60. Uteshev V.V., Tupal S., Mhaskar Y., Faingold C.L. Abnormal serotonin receptor expression in DBA/2 mice associated with susceptibility to sudden death due to respiratory arrest. Epilepsy Res 2010, 88:183-188.
61. Feller D.J., Bassir J.M., Crabbe J.C., Le Fevre C.A. Audiogenic seizure susceptibility in WSP and WSR mice. Epilepsia 1994, 35:861-867.